MassBank MassBank Search Contents Download

MassBank Record: PR302821

Hesperetin-7-O-rutinoside; LC-ESI-QTOF; MS2

Mass Spectrum
Chemical Structure
Generated by the Chemistry Development Kit (http://github.com/cdk)

ACCESSION: PR302821
RECORD_TITLE: Hesperetin-7-O-rutinoside; LC-ESI-QTOF; MS2
DATE: 2019.03.28
AUTHORS: Tetsuya Mori, Center for Sustainable Resource Science, RIKEN
LICENSE: CC BY-SA NC
PUBLICATION: Tsugawa H., Nakabayashi R., Mori T., Yamada Y., Takahashi M., Rai A., Sugiyama R., Yamamoto H., Nakaya T., Yamazaki M., Kooke R., Bac-Molenaar JA., Oztolan-Erol N., Keurentjes JJB., Arita M., Saito K. (2019) "A cheminformatics approach to characterize metabolomes in stable-isotope-labeled organisms" Nature Methods 16(4):295-298. [doi:10.1038/s41592-019-0358-2]
COMMENT: registered in RIKEN PlaSMA

CH$NAME: Hesperidin
CH$NAME: Cirantin
CH$NAME: Hesperidoside
CH$NAME: (2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one
CH$NAME: (2S)-5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxymethyl]oxan-2-yl]oxy-chroman-4-one
CH$NAME: Hesp-7-Glc-6pp-Rha
CH$NAME: Hesperetin 7-O-rutinoside
CH$NAME: Hesperetin 7-rhamnoglucoside
CH$COMPOUND_CLASS: Flavonoid-7-O-glycosides
CH$FORMULA: C28H34O15
CH$EXACT_MASS: 610.18977
CH$SMILES: C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O
CH$IUPAC: InChI=1S/C28H34O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-7,10,17,19,21-30,32-37H,8-9H2,1-2H3/t10-,17-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1
CH$LINK: CAS 520-26-3
CH$LINK: CHEBI 28775
CH$LINK: CHEMSPIDER 10176
CH$LINK: COMPTOX DTXSID9044328
CH$LINK: INCHIKEY QUQPHWDTPGMPEX-QJBIFVCTSA-N
CH$LINK: KEGG C09755
CH$LINK: KNAPSACK C00000970
CH$LINK: NIKKAJI J4.480F
CH$LINK: PUBCHEM CID:10621

AC$INSTRUMENT: LC, Waters Acquity UPLC System; MS, Waters Xevo G2 Q-Tof
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 6V
AC$MASS_SPECTROMETRY: DESOLVATION_GAS_FLOW 800/h
AC$MASS_SPECTROMETRY: DESOLVATION_TEMPERATURE 450 C
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$CHROMATOGRAPHY: CAPILLARY_VOLTAGE +3.00 kV
AC$CHROMATOGRAPHY: COLUMN_NAME Acquity bridged ethyl hybrid C18 (1.7 um, 2.1 mm * 100 mm, Waters)
AC$CHROMATOGRAPHY: COLUMN_TEMPERATURE 40 C
AC$CHROMATOGRAPHY: FLOW_GRADIENT A/B = (99.5%/0.5% at 0 min, 99.5%/0.5% at 0.1 min, 20%/80% at 10 min, 0.5%/99.5% at 10.1 min, 0.5%/99.5% at 12.0 min, 99.5%/0.5% at 12.1 min, 99.5%/0.5% at 15.0 min)
AC$CHROMATOGRAPHY: FLOW_RATE 0.3 ml/min at 0 min, 0.3 ml/min at 10 min, 0.4 ml/min at 10.1 min, 0.4 ml/min at 14.4 min, 0.3 ml/min at 14.5 min
AC$CHROMATOGRAPHY: RETENTION_TIME 4.507534
AC$CHROMATOGRAPHY: SOLVENT A water including 0.1% formic acid
AC$CHROMATOGRAPHY: SOLVENT B acetonitrile including 0.1% formic acid

MS$FOCUSED_ION: PRECURSOR_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 611.1970468

PK$SPLASH: splash10-0udi-0229501000-ab891673ea2b2724cbaf
PK$NUM_PEAK: 104
PK$PEAK: m/z int. rel.int.
  85.02859 54.0 54
  87.03072 15.0 15
  123.25112 10.0 10
  129.04817 18.0 18
  129.05443 65.0 65
  130.05295 10.0 10
  137.06158 10.0 10
  143.07246 22.0 22
  145.04865 15.0 15
  147.06361 92.0 92
  151.07353 13.0 13
  152.07756 13.0 13
  153.0175 27.0 27
  153.03189 10.0 10
  177.01508 11.0 11
  177.0537 144.0 144
  179.03728 23.0 23
  195.02826 148.0 148
  201.01059 16.0 16
  219.03128 71.0 71
  219.0513 14.0 14
  223.45648 10.0 10
  242.72629 12.0 12
  245.04471 87.0 87
  250.09073 16.0 16
  256.08954 15.0 15
  261.04187 19.0 19
  262.08548 11.0 11
  263.01315 15.0 15
  263.04367 24.0 24
  263.05835 36.0 36
  263.07315 22.0 22
  264.05249 12.0 12
  264.05923 24.0 24
  281.0629 97.0 97
  294.92856 11.0 11
  297.05121 17.0 17
  298.07834 13.0 13
  302.99063 14.0 14
  303.0029 16.0 16
  303.04272 21.0 21
  303.07782 422.0 422
  303.08731 1000.0 999
  304.07275 23.0 23
  304.09094 206.0 206
  305.08438 66.0 66
  305.67926 12.0 12
  306.0813 13.0 13
  315.08298 18.0 18
  315.10587 10.0 10
  316.09134 12.0 12
  327.09714 24.0 24
  328.06454 15.0 15
  339.10089 15.0 15
  345.0806 71.0 71
  345.09805 58.0 58
  345.11432 37.0 37
  346.09073 16.0 16
  346.10431 10.0 10
  367.11737 10.0 10
  369.08957 40.0 40
  369.10672 54.0 54
  370.08301 15.0 15
  370.10953 16.0 16
  370.76199 12.0 12
  381.0965 31.0 31
  385.57532 40.0 40
  389.07959 13.0 13
  391.66504 13.0 13
  395.10007 14.0 14
  400.10162 19.0 19
  406.80963 12.0 12
  412.96014 20.0 20
  413.12003 130.0 130
  414.13113 35.0 35
  429.11072 13.0 13
  431.11679 24.0 24
  431.14377 86.0 86
  431.1666 16.0 16
  432.14453 10.0 10
  437.1347 10.0 10
  439.10754 15.0 15
  447.13037 41.0 41
  448.12018 10.0 10
  448.13617 30.0 30
  449.12308 83.0 83
  449.14883 293.0 293
  450.12735 14.0 14
  450.15018 105.0 105
  465.13345 323.0 323
  465.15363 68.0 68
  466.13867 52.0 52
  471.12701 16.0 16
  489.12354 16.0 16
  490.14795 21.0 21
  507.14914 15.0 15
  530.159 12.0 12
  557.14178 12.0 12
  575.1698 14.0 14
  576.18658 12.0 12
  577.1983 12.0 12
  593.16736 10.0 10
  611.14124 10.0 10
  611.19421 327.0 327
//

Imprint Feedback
system version 2.1.8
Copyright © 2006 MassBank Project; 2011 NORMAN Association; 2021 MassBank Consortium
Responsible: Dr. Tobias Schulze